3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: December 2, 2024
Period of Report: December 2, 2024
Accession Number: 0001127602-24-028321

View Document ↗ View on SEC.gov ↗